5yfn
From Proteopedia
(Difference between revisions)
m (Protected "5yfn" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Human isocitrate dehydrogenase 1 bound with isocitrate== | |
| - | + | <StructureSection load='5yfn' size='340' side='right' caption='[[5yfn]], [[Resolution|resolution]] 2.50Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5yfn]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YFN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5YFN FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ICT:ISOCITRIC+ACID'>ICT</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | |
| - | [[Category: | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Isocitrate_dehydrogenase_(NADP(+)) Isocitrate dehydrogenase (NADP(+))], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.42 1.1.1.42] </span></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5yfn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5yfn OCA], [http://pdbe.org/5yfn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5yfn RCSB], [http://www.ebi.ac.uk/pdbsum/5yfn PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5yfn ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Disease == | ||
| + | [[http://www.uniprot.org/uniprot/IDHC_HUMAN IDHC_HUMAN]] Defects in IDH1 are involved in the development of glioma (GLM) [MIM:[http://omim.org/entry/137800 137800]]. Gliomas are central nervous system neoplasms derived from glial cells and comprise astrocytomas, glioblastoma multiforme, oligodendrogliomas, and ependymomas. Note=Mutations affecting Arg-132 are tissue-specific, and suggest that this residue plays a unique role in the development of high-grade gliomas. Mutations of Arg-132 to Cys, His, Leu or Ser abolish magnesium binding and abolish the conversion of isocitrate to alpha-ketoglutarate. Instead, alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate. Elevated levels of R(-)-2-hydroxyglutarate are correlated with an elevated risk of malignant brain tumors. | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Chen, D]] | ||
| + | [[Category: Jansson, A]] | ||
[[Category: Larsson, A]] | [[Category: Larsson, A]] | ||
[[Category: Nordlund, P]] | [[Category: Nordlund, P]] | ||
| - | [[Category: | + | [[Category: Cytosolic protein]] |
| - | [[Category: | + | [[Category: Idh1]] |
| + | [[Category: Isocitrate]] | ||
| + | [[Category: Nadph regeneration]] | ||
| + | [[Category: Oxidoreductase]] | ||
Revision as of 07:20, 25 October 2017
Human isocitrate dehydrogenase 1 bound with isocitrate
| |||||||||||
